| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/12/2007 | US20070161610 Bipolar trans carotenoid salts and their uses |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161584 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 07/12/2007 | US20070161558 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161073 Methods and products related to evaluating the quality of a polysaccharide |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160665 Chlorthalidone combinations |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | CA2841386A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2641421A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | CA2636929A1 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 07/12/2007 | CA2636278A1 A dietary fibre comprising water-soluble .beta.-glucan and use thereof for treating or preventing metabolic syndrome |
| 07/12/2007 | CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved |
| 07/12/2007 | CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | CA2634974A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2634743A1 Modified lysine-mimetic compounds |
| 07/12/2007 | CA2634120A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/11/2007 | EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1806133A1 Method for modifying the ambience, and spray liquid and sprayer used in the method |
| 07/11/2007 | EP1806130A1 Solid pharmaceutical composition comprising irbesartan |
| 07/11/2007 | EP1805219A1 Angiopoietin-2 specific binding agents |
| 07/11/2007 | EP1805180A1 Xanthine derivatives with hm74a receptor activity |
| 07/11/2007 | EP1804808A1 Pyridoxal-5-phosphate and stent for the treatment and prevention of atherosclerosis and restenosis |
| 07/11/2007 | EP1804807A2 Coadministration of tigecycline and digoxin |
| 07/11/2007 | EP1804795A2 Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease |
| 07/11/2007 | EP1804789A2 Method of treating human preeclampsia employing resibufagenin |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1497287A4 Quinolinone derivatives |
| 07/11/2007 | EP1455808B1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997655A Pyridyl-substituted porphyrin compounds and methods of use thereof |
| 07/11/2007 | CN1997651A Oxidative degradation products of atorvastatin calcium |
| 07/11/2007 | CN1997370A Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1997358A The use of kauranes compounds in the preparation of medicament |
| 07/11/2007 | CN1995041A Pyridazineindole derivative and its use |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1995019A Kukoline salt compounds and its preparation method |
| 07/11/2007 | CN1994454A Orally administered Chinese medicine for treating viral myocarditis caused by phlegm fire disturbing heart |
| 07/11/2007 | CN1994450A Medicament for treating piles |
| 07/11/2007 | CN1994449A Chinese medicine for treating coronary heart disease |
| 07/11/2007 | CN1994435A Chinese herbal tea preparation for treating acute viral myocarditis |
| 07/11/2007 | CN1994432A Medicament for treating hypertension |
| 07/11/2007 | CN1994426A Preparation method and quality control method of 'Sheng Mai' soft capsule |
| 07/11/2007 | CN1994425A Soft capsule of 'Sheng Mai' and preparation method thereof |
| 07/11/2007 | CN1994411A Medicine for treating cerebral apoplexy |
| 07/11/2007 | CN1994403A Pharmaceutical composition for promoting blood circulation and preparation method thereof |
| 07/11/2007 | CN1994385A Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 07/11/2007 | CN1994377A Medicine for treating hypertension and preparation process thereof |
| 07/11/2007 | CN1994373A Formulation with basil, ginkgo leaf and notoginseng, preparation process and quality control method |
| 07/11/2007 | CN1994371A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994370A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994369A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994368A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994367A Marine medicine for treating hypertension, preparation process and dispersible tablet thereof |
| 07/11/2007 | CN1994363A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994362A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994361A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994360A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994359A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994350A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994349A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994348A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994347A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994346A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994345A Compound Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 07/11/2007 | CN1994344A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994322A Deer heart powder capsule and preparation method thereof |
| 07/11/2007 | CN1994315A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994314A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994313A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994312A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994311A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994310A Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease and preparation process thereof |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994292A Injection liquid of sodium tanshinon IIA silite |
| 07/11/2007 | CN1994288A Red sage root salvianolic acid A tablet for treating cardiovascular disease and preparation process thereof |
| 07/11/2007 | CN1994280A Sustained-release micro-pellet of trimetazidine and preparation process thereof |
| 07/11/2007 | CN1994277A Solid preparation of salvianolic acid A of red sage root and preparation process thereof |
| 07/11/2007 | CN1994151A Functional beverage prepared from sweet potato stem and leaves |
| 07/11/2007 | CN1325933C Radioactive emission detector with position tracking system and application in therapeutical system and treatment process |
| 07/11/2007 | CN1325637C Ependymal neural stem cells and method for their isolation |
| 07/11/2007 | CN1325509C Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |